Abati A - Search Results

1

Detection of aneuploidy in mesothelioma cell lines by fluorescence in situ hybridization (FISH).

Abati A, Sanford J, Fetsch P, Pass H. Abati A, et al. Diagn Cytopathol. 1997 Apr;16(4):375-7. doi: 10.1002/(sici)1097-0339(199704)16:4<375::aid-dc16>3.0.co;2-h. Diagn Cytopathol. 1997. PMID: 9143836 No abstract available.

2

Fluorescence in situ hybridization (FISH): a user's guide to optimal preparation of cytologic specimens.

Abati A, Sanford JS, Fetsch P, Marincola FM, Wolman SR. Abati A, et al. Diagn Cytopathol. 1995 Dec;13(5):486-92. doi: 10.1002/dc.2840130518. Diagn Cytopathol. 1995. PMID: 8834324

3

Characteristics of nine newly derived mesothelioma cell lines.

Pass HI, Stevens EJ, Oie H, Tsokos MG, Abati AD, Fetsch PA, Mew DJ, Pogrebniak HW, Matthews WJ. Pass HI, et al. Among authors: abati ad. Ann Thorac Surg. 1995 Apr;59(4):835-44. doi: 10.1016/0003-4975(95)00045-m. Ann Thorac Surg. 1995. PMID: 7695406

4

Absence of SV-40 large T antigen (Tag) in malignant mesothelioma effusions: an immunocytochemical study.

Simsir A, Fetsch P, Bedrossian CW, Ioffe OB, Abati A. Simsir A, et al. Among authors: abati a. Diagn Cytopathol. 2001 Oct;25(4):203-7. doi: 10.1002/dc.2039. Diagn Cytopathol. 2001. PMID: 11599101

5

OV632 as a possible marker for malignant mesothelioma: high expectations; low specificity.

Abati A, Fetsch PA. Abati A, et al. Diagn Cytopathol. 1995 Feb;12(1):81-2. doi: 10.1002/dc.2840120119. Diagn Cytopathol. 1995. PMID: 7789255 No abstract available.

6

Hyaluronate binding probe and CD44 in the differential diagnosis of malignant effusions: disappointing results in cytology material.

Filie AC, Abati A, Fetsch P, Azumi N. Filie AC, et al. Among authors: abati a. Diagn Cytopathol. 1998 Jun;18(6):473-4. doi: 10.1002/(sici)1097-0339(199806)18:6<473::aid-dc19>3.0.co;2-e. Diagn Cytopathol. 1998. PMID: 9626526 No abstract available.

7

Genetic probes in cytology: principles and applications.

Wolman SR, Sanford JS, Flom K, Feiner H, Abati A, Bedrossian C. Wolman SR, et al. Among authors: abati a. Diagn Cytopathol. 1995 Dec;13(5):429-35. doi: 10.1002/dc.2840130511. Diagn Cytopathol. 1995. PMID: 8834317 Review. No abstract available.

8

The effects of antibody clone and pretreatment method on the results of HER2 immunostaining in cytologic samples of metastatic breast cancer: A query and a review of the literature.

Fetsch PA, Abati A. Fetsch PA, et al. Among authors: abati a. Diagn Cytopathol. 2007 Jun;35(6):319-28. doi: 10.1002/dc.20638. Diagn Cytopathol. 2007. PMID: 17497656

9

E-cadherin, N-cadherin, and calretinin in pleural effusions: the good, the bad, the worthless.

Simsir A, Fetsch P, Mehta D, Zakowski M, Abati A. Simsir A, et al. Among authors: abati a. Diagn Cytopathol. 1999 Mar;20(3):125-30. doi: 10.1002/(sici)1097-0339(199903)20:3<125::aid-dc3>3.0.co;2-v. Diagn Cytopathol. 1999. PMID: 10086235

10

Cytokeratin positivity in fine-needle aspirates of metastatic malignant melanoma: fact or fiction?

Fetsch PA, Marincola FM, Abati A. Fetsch PA, et al. Among authors: abati a. Diagn Cytopathol. 1999 Apr;20(4):249-52. doi: 10.1002/(sici)1097-0339(199904)20:4<249::aid-dc14>3.0.co;2-6. Diagn Cytopathol. 1999. PMID: 10204112 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

113 results

Search Page